Implementation of the First Available Long-Acting HIV Medication (Cabotegravir/Rilpivirine) Into Routine Clinical Care

Licencia

Derechos de autor 2025 Parth Mehra, MS-2, Wissam El Atrouni, M.D., Kelly Robertson, Pharm.D., Megan Herman, Pharm.D., Lisa Clough, M.D.

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0).